Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Genetic testing in steroid-resistant nephrotic syndrome: when and how?

Lovric S, Ashraf S, Tan W, Hildebrandt F.

Nephrol Dial Transplant. 2016 Nov;31(11):1802-1813. Epub 2015 Oct 27. Review.

PMID:
26507970
2.

Steroid Resistant Nephrotic Syndrome-Genetic Consideration.

Tasic V, Gucev Z, Polenakovic M.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(3):5-12. doi: 10.1515/prilozi-2015-0073. Review.

PMID:
27442391
3.

Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases.

Zhang ZW, Xu XC, Liu T, Yuan S.

Oxid Med Cell Longev. 2016;2016:6859523. doi: 10.1155/2016/6859523. Epub 2015 Nov 16. Review.

4.

Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature.

Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y.

Neurol Sci. 2016 Mar;37(3):423-30. doi: 10.1007/s10072-015-2414-8. Epub 2015 Nov 21.

PMID:
26590992
5.

Targeting autophagy and mitophagy for mitochondrial diseases treatment.

Villanueva Paz M, Cotán D, Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, de La Mata M, Delgado Pavón A, de Lavera I, Alcocer-Gómez E, Sánchez-Alcázar JA.

Expert Opin Ther Targets. 2016;20(4):487-500. doi: 10.1517/14728222.2016.1101068. Epub 2015 Nov 2. Review.

PMID:
26523761
6.

Nutraceuticals for blood pressure control.

Sirtori CR, Arnoldi A, Cicero AF.

Ann Med. 2015;47(6):447-56. doi: 10.3109/07853890.2015.1078905. Epub 2015 Sep 11. Review.

PMID:
26362125
7.

A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality.

Hackshaw-McGeagh LE, Perry RE, Leach VA, Qandil S, Jeffreys M, Martin RM, Lane JA.

Cancer Causes Control. 2015 Nov;26(11):1521-50. doi: 10.1007/s10552-015-0659-4. Epub 2015 Sep 9. Review.

8.

The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder.

Maurya PK, Noto C, Rizzo LB, Rios AC, Nunes SO, Barbosa DS, Sethi S, Zeni M, Mansur RB, Maes M, Brietzke E.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:134-44. doi: 10.1016/j.pnpbp.2015.08.016. Epub 2015 Sep 6. Review.

PMID:
26348786
9.

Empirical Drug Therapy for Idiopathic Male Infertility: What is the New Evidence?

Garg H, Kumar R.

Urology. 2015 Dec;86(6):1065-75. doi: 10.1016/j.urology.2015.07.030. Epub 2015 Aug 5. Review.

PMID:
26255035
10.

Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction.

Yang YK, Wang LP, Chen L, Yao XP, Yang KQ, Gao LG, Zhou XL.

Clin Chim Acta. 2015 Oct 23;450:83-9. doi: 10.1016/j.cca.2015.08.002. Epub 2015 Aug 6. Review.

PMID:
26254995
11.

Nutraceutical and Other Modalities for the Treatment of Headache.

Tepper SJ.

Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1018-31. doi: 10.1212/CON.0000000000000211. Review.

PMID:
26252588
12.

Preventive Migraine Treatment.

Silberstein SD.

Continuum (Minneap Minn). 2015 Aug;21(4 Headache):973-89. doi: 10.1212/CON.0000000000000199. Review.

13.

Therapeutic advances in Huntington's Disease.

Shannon KM, Fraint A.

Mov Disord. 2015 Sep 15;30(11):1539-46. doi: 10.1002/mds.26331. Epub 2015 Jul 30. Review.

PMID:
26226924
14.

Disease-modifying strategies for Parkinson's disease.

Kalia LV, Kalia SK, Lang AE.

Mov Disord. 2015 Sep 15;30(11):1442-50. doi: 10.1002/mds.26354. Epub 2015 Jul 24. Review.

PMID:
26208210
15.

Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials.

Banach M, Serban C, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Watts GF, Blumenthal RS, Lip GY, Mikhailidis DP, Sahebkar A; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Pharmacol Res. 2015 Sep;99:329-36. doi: 10.1016/j.phrs.2015.07.008. Epub 2015 Jul 17.

PMID:
26192349
16.

Molecular diagnosis of coenzyme Q10 deficiency.

Yubero D, Montero R, Armstrong J, Espinós C, Palau F, Santos-Ocaña C, Salviati L, Navas P, Artuch R.

Expert Rev Mol Diagn. 2015;15(8):1049-59. doi: 10.1586/14737159.2015.1062727. Epub 2015 Jul 4. Review.

PMID:
26144946
17.

MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.

El-Hattab AW, Adesina AM, Jones J, Scaglia F.

Mol Genet Metab. 2015 Sep-Oct;116(1-2):4-12. doi: 10.1016/j.ymgme.2015.06.004. Epub 2015 Jun 15. Review.

PMID:
26095523
18.

Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review.

Ramis MR, Esteban S, Miralles A, Tan DX, Reiter RJ.

Curr Med Chem. 2015;22(22):2690-711. Review.

PMID:
26087763
19.

Immunotherapy in antiphospholipid syndrome.

Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ.

Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Review.

PMID:
26086363
20.

The ratio of oxidized and reduced forms of selected antioxidants as a possible marker of oxidative stress in humans.

Kanďár R.

Biomed Chromatogr. 2016 Jan;30(1):13-28. doi: 10.1002/bmc.3529. Epub 2015 Jul 1. Review.

PMID:
26053056

Supplemental Content

Loading ...
Support Center